153 related articles for article (PubMed ID: 34688694)
1. Comparative study on the effect of aspirin, TP receptor antagonist and TxA
Ozen G; Aljesri K; Abdelazeem H; Norel X; Turkyılmaz G; Turkyılmaz S; Topal G
Life Sci; 2021 Dec; 286():120073. PubMed ID: 34688694
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
3. A novel inhibitory prostanoid receptor in piglet saphenous vein.
Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the COX/TXS/TP receptor pathway enhances uridine diphosphate-induced contraction by advanced glycation end products in rat carotid arteries.
Matsumoto T; Kojima M; Takayanagi K; Katome T; Taguchi K; Kobayashi T
Pflugers Arch; 2019 Dec; 471(11-12):1505-1517. PubMed ID: 31736003
[TBL] [Abstract][Full Text] [Related]
5. Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.
Stanke F; Cracowski JL; Chavanon O; Magne JL; Blin D; Bessard G; Devillier P
Eur J Pharmacol; 1998 Jan; 341(1):65-71. PubMed ID: 9489857
[TBL] [Abstract][Full Text] [Related]
6. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression.
Li M; Kuo L; Stallone JN
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2444-55. PubMed ID: 18310519
[TBL] [Abstract][Full Text] [Related]
7. Human vascular tissues produce thromboxane as well as prostacyclin.
Mehta J; Roberts A
Am J Physiol; 1983 Jun; 244(6):R839-44. PubMed ID: 6407339
[TBL] [Abstract][Full Text] [Related]
8. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
He GW; Yang CQ
J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
[TBL] [Abstract][Full Text] [Related]
9. Temperature-dependent basal tone in isolated human saphenous veins: implication of TP-receptors.
Simonet S; Bonhomme E; Fabiani JN; Verbeuren T
Fundam Clin Pharmacol; 2000; 14(5):461-7. PubMed ID: 11129086
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of coronary artery bypass graft materials: reduced contraction and ADMA levels in internal mammary artery versus saphenous vein.
Ozen G; Aljesri K; Turkyilmaz G; Turkyilmaz S; Kavala AA; Topal G; Norel X
J Cardiovasc Surg (Torino); 2022 Feb; 63(1):69-77. PubMed ID: 34472766
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the role of phospholipase A
Ahmad AA; Randall MD; Roberts RE
J Physiol; 2017 Nov; 595(21):6623-6634. PubMed ID: 28877347
[TBL] [Abstract][Full Text] [Related]
12. Noradrenaline-induced contraction of human saphenous vein and human internal mammary artery: involvement of different alpha-adrenoceptor subtypes.
Giessler C; Wangemann T; Silber RE; Dhein S; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):104-9. PubMed ID: 12122495
[TBL] [Abstract][Full Text] [Related]
13. The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation.
Rouaud C; Delaforge M; Anger-Leroy M; Le Filliatre G; Finet M; Hanf R
Br J Pharmacol; 1999 Jan; 126(1):35-44. PubMed ID: 10051118
[TBL] [Abstract][Full Text] [Related]
14. Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery.
Bishop-Bailey D; Pepper JR; Haddad EB; Newton R; Larkin SW; Mitchell JA
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1644-8. PubMed ID: 9327757
[TBL] [Abstract][Full Text] [Related]
15. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
[TBL] [Abstract][Full Text] [Related]
16. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
17. Different interactions of platelets with arterial and venous coronary bypass vessels.
Yang ZH; Stulz P; von Segesser L; Bauer E; Turina M; Lüscher TF
Lancet; 1991 Apr; 337(8747):939-43. PubMed ID: 1678031
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of thromboxane receptor-induced vasoconstriction in human saphenous vein.
Ozen G; Aljesri K; Celik Z; Turkyılmaz G; Turkyılmaz S; Teskin O; Norel X; Topal G
Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106476. PubMed ID: 32721526
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors.
Delannoy E; Courtois A; Freund-Michel V; Leblais V; Marthan R; Muller B
Cardiovasc Res; 2010 Feb; 85(3):582-92. PubMed ID: 19710084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
